Evidence map›Paper›PMID 41095891›Full record

ArticleJournal of clinical medicine2025

A Validation Approach for Determining Fetal Blood Groups Non-Invasively by High-Sensitive Next-Generation Sequencing.

Sandra Wienzek-Lischka, Marion Soelter, Annika Froelich, Marion Ernst-Schlegel, Stefan Gattenloehner, Andreas Braeuninger, Ulrich J Sachs

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sandra Wienzek-LischkaInstitute for Clinical Immunology, Transfusion Medicine and Haemostaseology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.
Marion SoelterInstitute for Clinical Immunology, Transfusion Medicine and Haemostaseology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.
Annika FroelichInstitute for Clinical Immunology, Transfusion Medicine and Haemostaseology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.
Marion Ernst-SchlegelInstitute for Clinical Immunology, Transfusion Medicine and Haemostaseology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.
Stefan GattenloehnerInstitute for Pathology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.
Andreas BraeuningerInstitute for Pathology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.
Ulrich J SachsInstitute for Clinical Immunology, Transfusion Medicine and Haemostaseology, Justus-Liebig-University Giessen, 35392 Giessen, Germany.ORCID 0000-0001-5486-5542

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-HPA-1aanti-Kcell-free DNA (cfDNA)fetal and neonatal alloimmune thrombocytopenia (FNAIT)hemolytic disease of the fetus and newborn (HDFN)HPA-1aIntegrin beta-3 (ITGB3)Kell (KEL)next-generation sequencing (NGS)non-invasive fetal blood group genotyping

Identifiers

PMID41095891
PMCPMC12524485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.